undamentalytics Newsletter
Sign in

Establishment Labs Holdings Inc. cash flow statement

In fiscal 2025, Establishment Labs Holdings Inc.'s operations generated −$50.9m of cash; it spent $6.0m on capital projects, leaving free cash flow of −$56.9m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−32−34−30−13−28−52−89−59−51−32
Depreciation and amortisation————33356—
Stock-based pay—776101314141112
Capital spending1262238669
Free cash flow−33−36−36−15−30−55−96−65−57−42
Free cash flow after stock pay—−43−43−20−40−68−111−79−68−54
Share buybacks50————————
Shares issued———640085990—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CERS vs ESTAESTA vs LMATESTA vs KIDSESTA vs SIBN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Establishment Labs Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Establishment Labs Holdings Inc.